A retrospective study of osimertinib in pretreated advanced non-small-cell lung cancer patients
Latest Information Update: 10 Jun 2021
At a glance
- Drugs Osimertinib (Primary)
- Indications Adenocarcinoma; Cancer metastases; Non-small cell lung cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2021 New trial record